Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix
Status:
Recruiting
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
The primary aim of the trial is to study the impact of nelfinavir on 3 year disease free
survival in patients with advanced carcinoma of cervix receiving standard chemoradiation
(Cisplatin and Radiotherapy).
There will be two study groups. One group will receive standard treatment (concurrent
chemoradiation and brachytherapy) & other group will receive nelfinavir 5-7 days prior to
standard treatment (chemoradiation & brachytherapy).